Findings support speech-based OSA screening as a low-burden complementary approach, while emphasizing the need for larger, balanced, and externally validated cohorts.
Abstract
This study investigates non-invasive detection of obstructive sleep apnea (OSA) from daytime speech in a limited polysomnography-labeled clinical cohort. The objective was to evaluate whether speaker-verification-inspired representations can support robust speech-based OSA screening under constrained clinical data conditions. We compared conventional mel-frequency cepstral coefficient (MFCC)-based classifiers with i-vector systems using cosine-similarity, support vector machine (SVM), and neural-network (NN) back ends, and included an exploratory ECAPA-TDNN embedding experiment using a pretrained frozen speaker model with prototype-based cosine scoring. Speech recordings from 93 participants were collected under controlled conditions and evaluated using subject-independent validation. Supervised i-vector back ends achieved the strongest performance. The i-vector SVM system obtained the highest numerical accuracy of 96.3% and the strongest threshold-independent performance, with AUC-ROC of 0.987 and AUC-PR of 0.992, while the i-vector NN system showed closely comparable performance with a non-significant AUC-ROC difference from i-vector SVM. ECAPA-TDNN showed moderate class separability but did not outperform the i-vector systems. Demographic-only and speech-demographic fusion analyses indicated that sex, age, and body mass index carried predictive information but did not fully explain the best speech-based performance. These findings support speech-based OSA screening as a low-burden complementary approach, while emphasizing the need for larger, balanced, and externally validated cohorts.
A lightweight deep learning model that detects apnea events using a single acoustic channel is proposed, demonstrating that respiratory sounds contain sufficient information for reliable apnea detection and validating their potential as a non-invasive, low-cost biomarker.
Joan S. Tunubalaa, Gissel V. Quitiana, Carlos M. Paredesa et al.· F1000Research· 0 citations
Background and Objectives This study compared four machine learning models in differentiating normal from pathological voice using key acoustic indices (Cepstral Peak Prominence Smoothed [CPPS], Acoustic Voice Quality Index [AVQI], and Acoustic Breathiness Index [ABI]) and identified the most effective algorithm for th...
Geun-Hyo Kim, Yeon-Woo Lee· Journal of The Korean Societ...· 0 citations
Early detection of Parkinson’s disease can facilitate timely intervention. Speech is a noninvasive and cost-effective biomarker for Parkinson’s disease detection. In this study, a subject-independent speech-based pipeline was developed using acoustic and nonlinear speech features. To avoid subject-level information lea...
Ashwini D. Bhople· Natural Resources for Human...· 0 citations
Background: Drug-Induced Sleep Endoscopy (DISE) is the current reference standard for identifying the anatomical site of upper airway obstruction in obstructive sleep apnea (OSA), but its invasiveness and limited availability restrict its routine use. Because snoring is generated by vibration of the obstructing upper-a...
F. Leone, F. Pietrogiacomi, L. Fiorini et al.· medRxiv· 0 citations
These findings apply to direct early concatenation with the shared 1D-CNN backbone and do not imply that feature fusion is generally ineffective, and do not imply that feature fusion is generally ineffective.
N. Smailov, M. Zhekambayeva, D. Bauyrzhankyzy et al.· Signals· 0 citations
A literature-guided, patient-independent comparison of ten BCG feature groups using a 512-sensor capacitive pressure mat recorded simultaneously with respiratory polygraphy in 155 patients undergoing in-hospital evaluation for obstructive sleep apnea shows that a compact, interpretable subset of the full feature librar...
I. C. Jurado, Z. Bousraou, Lara Benning et al.· 0 citations
We use cookies to run the site and, with your consent, for analytics and to show ads.
See our Cookie Policy.